Arkolith/Insider Trading/HOTH/Form 4

Knie Robb

CEO and President, DirectorHoth Therapeutics, Inc. (HOTH) · full profile →Form 4 · filed Aug 28, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 28, 2025Tax withholding(F)311K$1.21$376K547K
Aug 27, 2025Grant(A)800K—$0858K

Transaction Codes

F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-25-081945) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML